Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clinical Outcomes
74%
Percutaneous Coronary Intervention
58%
Coronary Artery Spasm
52%
Amlodipine
44%
Hypertension
42%
Acute Myocardial Infarction
39%
Hypertensive Patients
37%
Korean Patients
36%
Drug-eluting Stent
34%
95% Confidence Interval
32%
Randomized Double-blind
28%
Monotherapy
27%
Hazard Ratio
25%
Acetylcholine Provocation Test
24%
Systolic Blood Pressure
23%
Losartan
23%
New-onset Diabetes Mellitus
23%
Rosuvastatin
23%
Intracoronary Acetylcholine
22%
Arterial Stiffness
21%
Myocardial Infarction
20%
Blood Pressure
20%
Hypertensive
20%
Diabetes Mellitus
19%
Dyslipidemia
18%
Propensity Score Analysis
18%
Fixed-dose Combination
17%
Major Adverse Cardiac Events
17%
Coronary Artery Disease
16%
Vasospastic Angina
15%
Atorvastatin
15%
Major Adverse Cardiovascular Events
15%
Diastolic Blood Pressure
15%
Asian Population
15%
Korean Population
14%
Acute Myocardial Infarction Patients
14%
Patients with Hypertension
14%
Telmisartan
14%
Statins
14%
Acetylcholine
13%
Clinical Characteristics
13%
Sirolimus-eluting Stent
13%
Clinical Follow-up
13%
Central Blood Pressure
13%
High Incidence
13%
Serum Adiponectin
13%
Target Lesion Revascularization
13%
Angiographic Characteristics
12%
Adverse Events
12%
Target Vessel Revascularization
12%
Medicine and Dentistry
Percutaneous Coronary Intervention
56%
Drug-Eluting Stent
54%
Myocardial Infarction
52%
Coronary Vasospasm
48%
Coronary Artery Disease
45%
Acetylcholine
42%
Hypertension
40%
Diabetes Mellitus
37%
Blood Pressure
36%
Arterial Stiffness
35%
Cardiovascular Disease
32%
Acute Heart Infarction
31%
Provocation Test
30%
Pulse Wave Velocity
30%
Cardiovascular System
29%
Revascularization
24%
Atrial Fibrillation
21%
Systolic Blood Pressure
20%
Apoplexy
20%
Hazard Ratio
20%
Coronary Artery
19%
Left Atrium
18%
Rapamycin
17%
Thorax Pain
15%
Hemodynamic
15%
Angina pectoris
15%
Endothelial Dysfunction
15%
Multidetector Computed Tomography
14%
Target Lesion Revascularization
13%
Cardiovascular Risk
13%
Coronary Angiography
12%
Paclitaxel
12%
Chronic Total Occlusion
12%
Coronary Artery Obstruction
11%
Arteriosclerosis Obliterans
11%
Maturity Onset Diabetes of the Young
11%
Myocardial Bridge
11%
Major Adverse Cardiac Event
11%
Pulse Pressure
11%
Propensity Score Matching
11%
Cohort Effect
11%
Vasomotor Reflex
10%
Odds Ratio
10%
Percutaneous Transluminal Angioplasty
10%
Target Vessel Revascularization
10%
Diabetes
10%
Body Mass Index
10%
Left Coronary Artery
10%
Lipoprotein
10%
Stenting
9%
Pharmacology, Toxicology and Pharmaceutical Science
Hypertension
100%
Coronary Artery Spasm
48%
Diabetes Mellitus
44%
Acute Heart Infarction
39%
Amlodipine
38%
Acetylcholine
36%
Monotherapy
34%
Rosuvastatin
25%
Cardiovascular Disease
24%
Provocation Test
23%
Statin (Protein)
23%
Losartan
21%
Atorvastatin
21%
Adverse Event
20%
Antihypertensive Agent
19%
Heart Infarction
18%
Low Density Lipoprotein Cholesterol
18%
Major Adverse Cardiac Event
17%
Coronary Artery Disease
17%
Combination Therapy
16%
Dyslipidemia
16%
Clopidogrel
15%
Clinical Trial
15%
Cilostazol
13%
Telmisartan
12%
Antiplatelet
12%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
12%
Amlodipine Plus Telmisartan
12%
Calcium Channel Blocker
12%
Angiotensin Receptor Antagonist
12%
Restenosis
11%
ST Segment Elevation Myocardial Infarction
11%
Cerebrovascular Accident
11%
Essential Hypertension
11%
Atrial Fibrillation
10%
Hypercholesterolemia
10%
Hydrochlorothiazide
10%
Lipoprotein A
10%
C Reactive Protein
10%
Acetylsalicylic Acid
10%
Muscle Spasm
10%
Endothelial Dysfunction
9%
Tolerability
9%
Cholesterol
8%
Peripheral Occlusive Artery Disease
8%
Clinical Study
8%
Dipeptidyl Carboxypeptidase Inhibitor
8%
Observational Study
8%
Irbesartan
8%
Valsartan
8%